Does Blue Cross Blue Shield of Illinois Cover Wegovy?

In most cases, Blue Cross Blue Shield of Illinois does not cover Wegovy for weight loss. BCBSIL’s own guidance states that “most plans don’t cover GLP-1s for weight loss,” and whether your plan is an exception depends almost entirely on whether your employer chose to add weight-management drugs as a benefit. If Wegovy isn’t a covered benefit under your plan, you pay the full retail price.¹

Coverage Depends on Your Plan Type

BCBSIL sells and administers several categories of coverage, and the rules for Wegovy differ across them.

Large employer (self-funded) plans. Many large employers pay their own claims and decide which drugs to cover. Even though BCBSIL’s standard formulary excludes Wegovy, a self-funded employer can elect to add GLP-1 weight-management coverage as an optional benefit. BCBSIL treats this as an employer election and offers utilization management and metabolic health programs to groups that opt in.²

Small employer plans. Small groups typically follow BCBSIL’s standard formulary without customization. Wegovy is not listed on the Performance Select or Multi-Tier Basic drug lists for 2026, so small-group members generally have no coverage unless the employer has specifically added the weight-management benefit.³⁴

Individual and ACA Marketplace plans. BCBSIL’s standard formulary notes that “some plans may exclude coverage for certain agents or drug categories, like those used for…weight loss.”⁵ Weight-loss drugs are almost always excluded from individual marketplace plans, and because the exclusion is written into the plan design, appeals rarely succeed.

Illinois state employees. Active state employees and their dependents have a different rule. Effective July 1, 2024, Illinois law requires the State Employees Group Insurance Program to cover injectable weight-loss or glucose-management drugs, specifically including Wegovy, for adults diagnosed with prediabetes, gestational diabetes, or obesity.⁶ The medication must be deemed medically appropriate by a physician, and the member has to enroll in a lifestyle management program after the initial prescription. Skipping the lifestyle program means refills get denied.⁷ This mandate applies only to the nine plans offered to active state employees and their dependents. It does not extend to Medicaid, state retirees on Medicare Advantage, or private commercial insurance. As of 2026, Illinois has not required private insurers to cover anti-obesity medications.⁸

How to Check Your Own Plan

The reliable ways to confirm whether your plan covers Wegovy are to log in to Blue Access for Members at bcbsil.com or call the customer service number on the back of your ID card.¹ If your coverage comes through an employer, HR or the benefits administrator can also tell you whether the group elected GLP-1 weight-management coverage. The generic formulary on the BCBSIL website will not answer the question by itself, because coverage is decided at the plan level.

Requirements if Your Plan Does Cover It

Coverage doesn’t mean automatic access. Every plan that covers Wegovy requires prior authorization, administered by BCBSIL’s pharmacy benefit manager, Prime Therapeutics.⁹ Under the Weight Loss Prior Authorization program summary effective June 2026, the patient must meet all of the following:¹⁰

Followed a low-calorie diet, increased physical activity, and behavioral modifications for at least six months before starting the drug, and continued them during treatment.
For adults 18 and older: BMI of 30 or higher, or BMI of 27 or higher with a weight-related condition such as diabetes, high cholesterol, or coronary artery disease. Lower thresholds (25 for obesity, 23 for overweight) apply to patients of South Asian, Southeast Asian, or East Asian descent.
For adolescents 12 to 17: BMI at or above the 95th percentile for age and sex, or at or above the 85th percentile with a weight-related condition.
Not using Wegovy alongside another weight-loss drug such as phentermine, Qsymia, Contrave, Saxenda, or Zepbound.
No FDA-labeled contraindication to the medication.

Initial approval usually runs 12 months for marketplace and many fully insured plans, but some administrative-services-only plans start with a three-month approval. Renewal requires documented weight loss of at least 5% from the pre-treatment baseline (or a 5% BMI reduction for pediatric patients), continued lifestyle participation, no combination weight-loss therapy, and no new contraindications. If those are met, authorization is generally extended for another 12 months.¹⁰

Fills may also be capped at 30 days. Since September 1, 2024, BCBSIL has offered employer groups an optional 30-day supply limit for GLP-1 and anti-obesity drugs, including Wegovy, to reduce waste and control cost. A separate “GLP-1 New to Therapy” program, in place since April 2024, limits initial fills to 30 days for members new to GLP-1 therapy; longer supplies may be available after that depending on the plan.¹¹¹²

What to Do if You’re Denied

Start with the Explanation of Benefits, available through Blue Access for Members or by mail, and read the reason for the denial. If it’s an administrative error, customer service or a resubmitted claim from your prescriber may fix it.¹³

If the denial cites medical necessity or plan criteria, you and your prescriber can file a formal appeal. A standard appeal takes about 30 days, sometimes up to 60. Urgent appeals involving a health or safety risk are decided within 72 hours.¹³

If the internal appeal is denied, Illinois law gives you a right to external review through the Illinois Department of Insurance. An Independent Review Organization approved by the state examines the case at no cost. The request has to be filed within four months of the insurer’s final denial, and expedited review is available in urgent cases. Requests can be submitted online, by email, fax, or mail.¹⁴

One caveat matters here. If your plan is self-funded by your employer, it may fall outside the Illinois Department of Insurance’s external-review jurisdiction. Self-funded plans are governed by federal ERISA rules and run their own appeal processes; check your benefit booklet.

If the denial is based on a plan exclusion rather than a medical judgment (the plan simply doesn’t cover weight-loss drugs), an appeal is unlikely to change the outcome. In that case, the more productive path is to ask your employer’s HR whether weight-management coverage could be added in a future plan year.

Lowering the Cost if Coverage Isn’t There

Novo Nordisk, the manufacturer of Wegovy, runs a savings card that can bring the out-of-pocket cost down to as little as $25 per month for eligible patients with commercial insurance, up to a maximum savings of $100 per month. Most BCBSIL employer-sponsored coverage counts as commercial.¹⁵

The card can’t be used with government-funded insurance, meaning Medicaid and Medicare. Federal Employees Health Benefits plans, ACA Marketplace plans, and state employee plans are not treated as government insurance for this offer and remain eligible. The savings card stacks on top of insurance, so if your plan covers Wegovy with a copay or coinsurance, the card can further reduce what you owe.¹⁵

1
BCBSIL. GLP-1s for Weight Loss
2
BCBSIL. New GLP-1 Coverage 2026
3
BCBSIL. Performance Select Drug List 2026
4
BCBSIL. Multi-Tier Basic Annual Drug List 2026
5
BCBSIL. Performance Annual Drug List 2026
6
Becker’s Payer. Illinois Expands Weight Loss Drug Coverage to State Employees
7
State of Illinois Central Management Services. Summary of Benefits and Coverage
8
MultiState. GLP-1 Weight Loss Drugs Coverage Under Medicaid and Other Health Plans
9
BCBSIL. PA and ST Programs
10
Prime Therapeutics. HCSC Weight Loss Program Summary
11
BCBSIL. 30-Day Supply Limit
12
BCBSIL. GLP-1 New to Therapy
13
BCBSIL. Claims and Coverage FAQs
14
Illinois Department of Insurance. File an External Review
15
Novo Nordisk. Wegovy Savings Offer